Author:
dos Santos Lucivania Rodrigues,Carvalho Adonias Almeida,Rai Mahendra,Vieira Junior Gerardo Magela,Chaves Mariana Helena
Publisher
Springer Nature Singapore
Reference106 articles.
1. Abrahams S, Miller HC, Lombard C, van der Westhuizen FH, Bardien S (2021) Curcumin pre-treatment may protect against mitochondrial damage in LRRK2-mutant Parkinson’s disease and healthy control fibroblasts. Biochem Biophys Rep 27:101035
2. Ahmadi M, Agah E, Nafissi S, Jaafari MR, Harirchian MH, Sarraf P, Faghihi Kashani S, Hosseini SJ, Ghoreishi A, Aghamollaii V, Hosseini M, Tafakhori A (2018) Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial. Neurotherapeutics 15(2):430–438
3. Ahmed A, Ghallab EH, Shehata M, Zekri A-RN, Ahmed OS (2020) Impact of nano-conjugate on Drosophila for early diagnosis of Alzheimer’s disease. Nanotechnology 31(36):365102
4. Akram M, Shahab-Uddin AA, Usmanghani K, Hannan A, Mohiuddin E, Asif M (2010) Curcuma longa and curcumin: a review article. Rom J Biol Plant Biol 55(2):65–70
5. Alamro AA, Alsulami EA, Almutlaq M, Alghamedi A, Alokail M, Haq SH (2020) Therapeutic potential of vitamin D and curcumin in an in vitro model of Alzheimer disease. J Cent Nerv Syst Dis 12:1–8